Comparison between Entero Healthcare Solutions IPO and Platinum Industries IPO.
Entero Healthcare Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Platinum Industries IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Entero Healthcare Solutions IPO is up to ₹1,600.00 Cr whereas the issue size of the Platinum Industries IPO is up to ₹235.32 Cr. The final issue price of Entero Healthcare Solutions IPO is ₹1,258.00 per share and of Platinum Industries IPO is ₹171.00 per share.
| Entero Healthcare Solutions IPO | Platinum Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,195.00 per share | ₹162.00 per share |
| Issue Price (Upper) | ₹1,258.00 per share | ₹171.00 per share |
| Issue Price (Final) | ₹1,258.00 per share | ₹171.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹119.00 per share | |
| Market Lot Size | 11 shares | 87 shares |
| Fresh Issue Size | 79,52,518 shares | 1,37,61,225 shares |
| Fresh Issue Size (Amount) | up to ₹1,000.31 Cr | up to ₹235.32 Cr |
| OFS Issue Size | 47,67,526 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹599.69 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,27,20,044 shares | 1,37,61,225 shares |
| Issue Size Total (Amount) | up to ₹1,600.00 Cr | up to ₹235.32 Cr |
Entero Healthcare Solutions IPO opens on Feb 09, 2024, while Platinum Industries IPO opens on Feb 27, 2024. The closing date of Entero Healthcare Solutions IPO and Platinum Industries IPO is Feb 13, 2024, and Feb 29, 2024, respectively.
| Entero Healthcare Solutions IPO | Platinum Industries IPO | |
|---|---|---|
| Anchor Bid Date | Feb 08, 2024 | Feb 26, 2024 |
| Issue Open | Feb 09, 2024 | Feb 27, 2024 |
| Issue Close | Feb 13, 2024 | Feb 29, 2024 |
| Basis Of Allotment (Tentative) | Feb 14, 2024 | Mar 01, 2024 |
| Initiation of Refunds (Tentative) | Feb 15, 2024 | Mar 04, 2024 |
| Credit of Share (Tentative) | Feb 15, 2024 | Mar 04, 2024 |
| Listing date (Tentative) | Feb 16, 2024 | Mar 05, 2024 |
| Anchor Lockin End date 1 | Mar 15, 2024 | Mar 31, 2024 |
| Anchor Lockin End date 2 | May 14, 2024 | May 30, 2024 |
Entero Healthcare Solutions IPO P/E ratio is 0, as compared to Platinum Industries IPO P/E ratio of 18.73.
| Entero Healthcare Solutions IPO | Platinum Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.11 | 94.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 0 | 18.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3021.21 Cr. | ₹939.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -2.66% | 90.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 6.06% | 56.85% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.45 | 0.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.00 | ₹9.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -1.86% | 61.26% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Entero Healthcare Solutions IPO Retail Individual Investors (RII) are offered 12,65,500 shares while in Platinum Industries IPO retail investors are offered 12,65,500 shares. Qualified Institutional Buyers (QIB) are offered 37,96,503 shares in Entero Healthcare Solutions IPO and 27,52,375 shares in Platinum Industries IPO.
| Entero Healthcare Solutions IPO | Platinum Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,94,753 shares | 41,28,237 shares |
| Market Maker Reservation | ||
| QIB | 37,96,503 shares | 27,52,375 shares |
| NII | 18,98,251 shares | 20,64,184 shares |
| RII | 12,65,500 shares | 48,16,429 shares |
| Employee | 70,237 shares | |
| Others | ||
| Total | 1,27,25,244 shares | 1,37,61,225 shares |
Entero Healthcare Solutions IPO subscribed 1.53x in total, whereas Platinum Industries IPO subscribed 98.99x.
| Entero Healthcare Solutions IPO | Platinum Industries IPO | |
|---|---|---|
| QIB (times) | 2.28x | 151.00x |
| NII (times) | 0.22x | 141.79x |
| Big NII (times) | 0.16x | 138.46x |
| Small NII (times) | 0.33x | 148.46x |
| RII (times) | 1.33x | 50.92x |
| Employee (times) | 1.25x | |
| Other (times) | ||
| Total (times) | 1.53x | 98.99x |
